Evidence map›Paper›PMID 18991955›Full record

ReviewAnnals of the New York Academy of Sciences2008

ADHD and smoking: from genes to brain to behavior.

Francis Joseph McClernon, Scott Haden Kollins

Abstract readReview
In one paragraph

Review in Annals of the New York Academy of Sciences, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 90 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
90citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

90 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Effects of nicotine deprivation and replacement on BOLD-fMRI response to smoking cues as a function of DRD4 VNTR genotype.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2014
    Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

30 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Francis Joseph McClernonDepartment of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC 27708, USA. mccle011@mc.duke.edu
Scott Haden Kollins

Funding

Smoking/Nicotine Dependence in Attention Deficit Hyperactivity Disorder (ADHD)K24DA023464 · NIDA · DUKE UNIVERSITY · PI KOLLINS, SCOTT H · 2008 to 2018
$1.5M
Neuroimaging Attentional Impairment During AbstinenceK23DA017261 · NIDA · DUKE UNIVERSITY · PI MCCLERNON, FRANCIS JOSEPH · 2004 to 2008
$739k
Mechanisms of Nicotine Dependence in ADHD AdultsR21DA020806 · NIDA · DUKE UNIVERSITY · PI KOLLINS, SCOTT H · 2007 to 2008
$425k
NIDA NIH HHS K23 DA017261NIDA NIH HHS K24 DA023464NIDA NIH HHS R21 DA020806
6 · The paper itself

Abstract

Attention-deficit/hyperactivity disorder (ADHD) and tobacco smoking are among the most common and costly psychiatric and behavioral problems. The rates of co-occurrence of these two common problems are larger than expected by chance. Despite progress in identifying the neural and genetic substrates of each, the mechanisms underlying the high rates of comorbidity between ADHD and smoking remain largely unknown. We propose that ADHD and smoking involve dysregulation of dopaminergic and nicotinic-acetylcholinergic circuits and that these aberrations are likely to arise, at least in part, from genetic variations. This review describes an integrative model of the ADHD-smoking comorbidity, with an emphasis on shared neuropharmacological mechanisms. We first describe the prevalence of smoking among ADHD patients. We then describe how ADHD influences stages of smoking behavior (e.g., initiation, maintenance, and relapse). We review common potential genetic substrates of ADHD and smoking, focusing on genes that regulate monoaminergic neurotransmission. We review the behavioral and neuropharmacological bases of smoking and ADHD, focusing on the modulatory roles of nicotine on attention and behavioral control. Finally, we discuss the implications of this model for prevention and clinical outcomes.

Indexed as

AcetylcholineAdolescentAdultAge of OnsetAttention Deficit Disorder with HyperactivityComorbidityDopamineFemaleGenetic Predisposition to DiseaseHumansMaleNerve Tissue ProteinsNicotinePrevalenceSerotoninSmokingAcetylcholineDopamineNerve Tissue ProteinsNicotineSerotonin

Identifiers

PMID18991955
PMCPMC2758663

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.